Global Liver Disease Diagnostics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Liver Disease Diagnostics market size will reach 16,466 Million USD in 2025 and is projected to reach 27,353 Million USD by 2032, with a CAGR of 7.52% (2025-2032). Notably, the China Liver Disease Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Liver disease diagnostics encompass a range of methods and tests used to detect, evaluate, and monitor diseases affecting the liver. These diagnostics include blood tests, imaging studies, and liver biopsy. Blood tests, such as liver function tests (LFTs), measure levels of enzymes, proteins, and bilirubin in the blood to assess liver health and function. Imaging studies, including ultrasound, CT scans, and MRI, provide detailed visuals of the liver's structure, helping to identify abnormalities like tumors, cysts, or fatty deposits. Advanced imaging techniques like FibroScan measure liver stiffness to evaluate fibrosis and cirrhosis. A liver biopsy, where a small tissue sample is taken and examined microscopically, provides definitive information on liver inflammation, fibrosis, and the presence of conditions like hepatitis or liver cancer. Together, these diagnostic tools enable comprehensive assessment and effective management of liver diseases, guiding treatment decisions and monitoring disease progression.
The major global suppliers of Liver Disease Diagnostics include Abbott, Roche, Thermo Fisher Scientific, Randox Laboratories, Boston Scientific Corporation, LabCorp, Fujifilm Corporation, Horiba Medical, Siemens Healthcare GmbH, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Liver Disease Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Liver Disease Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Liver Disease Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Liver Disease Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Liver Disease Diagnostics Include:
Abbott
Roche
Thermo Fisher Scientific
Randox Laboratories
Boston Scientific Corporation
LabCorp
Fujifilm Corporation
Horiba Medical
Siemens Healthcare GmbH
Liver Disease Diagnostics Product Segment Include:
Imaging Tests
Blood Tests
Biopsy
Other
Liver Disease Diagnostics Product Application Include:
Hospitals
Laboratories
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Liver Disease Diagnostics Industry PESTEL Analysis
Chapter 3: Global Liver Disease Diagnostics Industry Porter's Five Forces Analysis
Chapter 4: Global Liver Disease Diagnostics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Liver Disease Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Liver Disease Diagnostics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Liver Disease Diagnostics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Liver Disease Diagnostics market size will reach 16,466 Million USD in 2025 and is projected to reach 27,353 Million USD by 2032, with a CAGR of 7.52% (2025-2032). Notably, the China Liver Disease Diagnostics market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Liver disease diagnostics encompass a range of methods and tests used to detect, evaluate, and monitor diseases affecting the liver. These diagnostics include blood tests, imaging studies, and liver biopsy. Blood tests, such as liver function tests (LFTs), measure levels of enzymes, proteins, and bilirubin in the blood to assess liver health and function. Imaging studies, including ultrasound, CT scans, and MRI, provide detailed visuals of the liver's structure, helping to identify abnormalities like tumors, cysts, or fatty deposits. Advanced imaging techniques like FibroScan measure liver stiffness to evaluate fibrosis and cirrhosis. A liver biopsy, where a small tissue sample is taken and examined microscopically, provides definitive information on liver inflammation, fibrosis, and the presence of conditions like hepatitis or liver cancer. Together, these diagnostic tools enable comprehensive assessment and effective management of liver diseases, guiding treatment decisions and monitoring disease progression.
The major global suppliers of Liver Disease Diagnostics include Abbott, Roche, Thermo Fisher Scientific, Randox Laboratories, Boston Scientific Corporation, LabCorp, Fujifilm Corporation, Horiba Medical, Siemens Healthcare GmbH, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Liver Disease Diagnostics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Liver Disease Diagnostics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Liver Disease Diagnostics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Liver Disease Diagnostics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Liver Disease Diagnostics Include:
Abbott
Roche
Thermo Fisher Scientific
Randox Laboratories
Boston Scientific Corporation
LabCorp
Fujifilm Corporation
Horiba Medical
Siemens Healthcare GmbH
Liver Disease Diagnostics Product Segment Include:
Imaging Tests
Blood Tests
Biopsy
Other
Liver Disease Diagnostics Product Application Include:
Hospitals
Laboratories
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Liver Disease Diagnostics Industry PESTEL Analysis
Chapter 3: Global Liver Disease Diagnostics Industry Porter's Five Forces Analysis
Chapter 4: Global Liver Disease Diagnostics Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Liver Disease Diagnostics Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Liver Disease Diagnostics Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Liver Disease Diagnostics Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Liver Disease Diagnostics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Liver Disease Diagnostics Product by Type
- 1.2.1 Imaging Tests
- 1.2.2 Blood Tests
- 1.2.3 Biopsy
- 1.2.4 Other
- 1.3 Liver Disease Diagnostics Product by Application
- 1.3.1 Hospitals
- 1.3.2 Laboratories
- 1.3.3 Others
- 1.4 Global Liver Disease Diagnostics Market Size Analysis (2020-2032)
- 1.5 Liver Disease Diagnostics Market Development Status and Trends
- 1.5.1 Liver Disease Diagnostics Industry Development Status Analysis
- 1.5.2 Liver Disease Diagnostics Industry Development Trends Analysis
- 2 Liver Disease Diagnostics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Liver Disease Diagnostics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Liver Disease Diagnostics Market Analysis by Country
- 4.1 Global Liver Disease Diagnostics Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Liver Disease Diagnostics Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Liver Disease Diagnostics Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.5 China Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.6 France Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.14 India Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Liver Disease Diagnostics Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Liver Disease Diagnostics Market Revenue by Key Suppliers (2021-2025)
- 5.2 Liver Disease Diagnostics Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Liver Disease Diagnostics Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Liver Disease Diagnostics Market Analysis by Type
- 6.1 Global Liver Disease Diagnostics Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Liver Disease Diagnostics Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Abbott
- 7.1.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Abbott Liver Disease Diagnostics Product Portfolio
- 7.1.3 Abbott Liver Disease Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Roche
- 7.2.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Roche Liver Disease Diagnostics Product Portfolio
- 7.2.3 Roche Liver Disease Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Thermo Fisher Scientific
- 7.3.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Thermo Fisher Scientific Liver Disease Diagnostics Product Portfolio
- 7.3.3 Thermo Fisher Scientific Liver Disease Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Randox Laboratories
- 7.4.1 Randox Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Randox Laboratories Liver Disease Diagnostics Product Portfolio
- 7.4.3 Randox Laboratories Liver Disease Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Boston Scientific Corporation
- 7.5.1 Boston Scientific Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Boston Scientific Corporation Liver Disease Diagnostics Product Portfolio
- 7.5.3 Boston Scientific Corporation Liver Disease Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 LabCorp
- 7.6.1 LabCorp Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 LabCorp Liver Disease Diagnostics Product Portfolio
- 7.6.3 LabCorp Liver Disease Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Fujifilm Corporation
- 7.7.1 Fujifilm Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Fujifilm Corporation Liver Disease Diagnostics Product Portfolio
- 7.7.3 Fujifilm Corporation Liver Disease Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Horiba Medical
- 7.8.1 Horiba Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Horiba Medical Liver Disease Diagnostics Product Portfolio
- 7.8.3 Horiba Medical Liver Disease Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Siemens Healthcare GmbH
- 7.9.1 Siemens Healthcare GmbH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Siemens Healthcare GmbH Liver Disease Diagnostics Product Portfolio
- 7.9.3 Siemens Healthcare GmbH Liver Disease Diagnostics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Liver Disease Diagnostics Industry Chain Analysis
- 8.2 Liver Disease Diagnostics Product Downstream Application Analysis
- 8.2.1 Global Liver Disease Diagnostics Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Liver Disease Diagnostics Revenue and Forecast by Application (2020-2032)
- 8.3 Liver Disease Diagnostics Typical Downstream Customers
- 8.4 Liver Disease Diagnostics Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
